This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Should You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?
by Zacks Equity Research
Sector ETF report for PRN
Should You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?
by Zacks Equity Research
Sector ETF report for PRN
Should You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?
by Zacks Equity Research
Sector ETF report for PRN
Should You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?
by Zacks Equity Research
Sector ETF report for PRN
5 Best-Performing Top-Ranked ETFs at the Start of May
by Sweta Killa
Wall Street regained momentum at the start of May. The rally has been broad-based, with all three major indices just a few points away from their record highs.
Top-Ranked ETFs That Outperformed the Market in Q1
by Sweta Killa
Wall Street wrapped up the first quarter with a big bang, driven by strong corporate profits, enthusiasm around AI and hopes that the Fed will cut rates.
Buy 5 Top-Ranked ETFs to Play Broadening US Market Rally
by Sanghamitra Saha
There is a shift towards a more inclusive approach to stock market investments, helped by a promising economic outlook and supportive monetary policies. Somewhat ebbing AI mania and regulatory woes probably are leading Investors to look beyond Magnificent Seven.
Should You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?
by Zacks Equity Research
Sector ETF report for PRN
5 Top-Ranked ETFs at New Highs Set to Soar Further
by Sweta Killa
Given the bullishness, many ETFs, having a solid Zacks ETF Rank #1 (Strong Buy) or 2 (Buy), touched new 52-week high and are expected to soar further.
ETFs in Focus Post Hawkish Powell Speech
by Sweta Killa
The Federal Reserve Chair Jerome Powell in the Jackson Hole symposium warned that the central bank is prepared to raise interest rates further and keep the borrowing costs high until inflation comes in the target range of 2%.